Strategies to Restore Mitochondrial Function and Support Healthy Aging: The Role of Urolithin A
Mitochondrial decline is one of the core biological drivers of aging, contributing to fatigue, loss of muscle, slower recovery, and reduced resilience across nearly every organ system.
In this conversation, Dr. Kara Fitzgerald and Dr. Anurag Singh reviewed the clinical science behind mitophagy, the cellular renewal process that clears damaged mitochondria and restores energy production.
They covered how the postbiotic nutrient Urolithin A supports mitochondrial quality control and how emerging human trials are translating into real-world clinical application.
In this webinar, you’ll learn:
- What Urolithin A is and how it’s produced (plus, why most people can’t get enough through food)
- How mitochondrial decline impacts aging, and why mitophagy is a critical step
- Key findings from human clinical trials on the benefits of Urolithin A
- Patients who can benefit from taking Urolithin A and practical considerations for including in your protocols
Live attendees joined the Q&A and had their questions answered in real time.
Access the Webinar Recording & Resources
Enter your email to watch the full webinar and receive the slides and Q&A. You’ll also be subscribed to our Functional Medicine & Longevity Newsletter, delivering emerging science and clinical insights translated for real-world practice through Dr. Fitzgerald’s lens.
Give your patients access to the only clinically validated Urolithin A on the market. Join Timeline’s provider network to unlock exclusive practitioner pricing, detailed clinical protocols, and resources designed to help you integrate Mitopure® into your practice.
Dr. Anurag Singh, MD, PhD

Dr. Anurag Singh is currently Chief Medical Officer at Timeline that develops next generation advanced nutritional and skincare products targeting improvements in mitochondrial and cellular health. With a M.D. in internal medicine and a Ph.D. in immunology, his experience includes work at top consumer health (Nestlé, Nestlé Health Science) and startups companies (Amazentis/Timeline).
He’s authored > 40 articles for top science journals, been awarded >15 patents and has designed and led > 50 randomized clinical trials. His research over the past decade across multiple clinical trials on the postbiotic Urolithin A and its health benefits has led to the launch of multiple consumer products.




